Treatment & Prognosis

Inflammation is the primary expression of psoriatic arthritis, therefore treatment is usually focused on reducing and controlling inflammation, with careful monitoring of patient response to prevent irreversible joint destruction early on.  

In most cases, psoriatic arthritis can be managed with NSAIDs (non-steroidal anti-inflammatory drugs).

Inflammation that isn’t controlled by NSAIDs can often be addressed with one of many types of DMARDs (disease-modifying anti-rheumatic drugs), a category of unrelated medications that share common ability to slow down progression of many rheumatic diseases.

Biologics (medical products derived from biologic processes, rather than chemical manufacture) are also quite effective in targeting the molecule responsible for systemic inflammation in the joints, and are often prescribed for psoriatic arthritis.

Your physician may choose one or more other medications to treat psoriatic arthritis, include antimalarial drugs, or corticosteroids, though these are less commonly prescribed or acknowledged for their general efficacy.  Injectable corticosteroids can be effective in helping to control inflammation.

In rare cases where PSA-related pain is intolerable, or there has been a complete loss of joint functioning, surgery is often an option.

Thanks to the variety of drug therapy options available today, prognosis for psoriatic arthritis sufferers is generally good.

However, there is no known cure, and some patients will find that their lives are altered by the disease, based on their sub-type (ie. symmetry, spread and severity of the disease), and the degree to which permanent joint damage has occurred.